๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Diabetic Kidney Disease

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus NCT05692388n/a1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Patient and Community Stakeholder Interviews, Cross-sectional Study Participants, Focus Groups and Intervention Mapping Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease NCT06969807Phase 26 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Amimestrocel Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. NCT04931537n/a1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ China Kidney Patient Trials Network NCT05036850n/a1 site๐Ÿ“ Beijing George (Beijing) Clinical Research Co. Ltd. Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes NCT05822609Phase 24 sites๐Ÿ“ Aurora๐Ÿ“ Seattle๐Ÿ“ Spokane University of Washington ยท Tests: Semaglutide, Placebo Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes NCT06586203NA2 sites๐Ÿ“ Montreal๐Ÿ“ Montreal Optithera ยท Tests: Polygenic Risk Score The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy NCT06843304n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital Real World Evidence Clinical Utility Study of KidneyIntelX NCT04802395n/a1 site๐Ÿ“ New York Renalytix AI, Inc. ยท Tests: KidneyIntelX Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps) NCT06821919n/a1 site๐Ÿ“ Nahariya Western Galilee Hospital-Nahariya Remote Ischemic Preconditioning in Type 2 Diabetic Patients Undergoing CABG NCT06977230NA2 sites๐Ÿ“ MuฤŸla๐Ÿ“ MuฤŸla MuฤŸla Sฤฑtkฤฑ Koรงman University ยท Tests: Remote Ischemic Preconditioning Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis NCT07010250n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris Mechanism of SGLT2 Inhibition in the Kidney NCT06291155Phase 41 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: SGLT2 inhibitor Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD) NCT07434791NA1 site๐Ÿ“ Toronto Sunnybrook Health Sciences Centre ยท Tests: Early goal-directed Cardio-Kidney-Metabolic (CKM) care, Standard care (Comparison arm) Lactoferrin Supplementation in Diabetic Nephropathy NCT07764991Phase 21 site๐Ÿ“ Cairo Ain Shams University ยท Tests: Lactoferrin, Antidiabetic, Placebo Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy NCT05888909n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital Efficacy and Safety Study of Isuzinaxib in Subjects With DKD NCT06962098Phase 220 sites๐Ÿ“ Ansan-si๐Ÿ“ Busan๐Ÿ“ Busan Aptabio Therapeutics, Inc. ยท Tests: Isuzinaxib, Placebo Prediction of Peripheral Neuropathy With Functional Testing NCT06933108n/a1 site๐Ÿ“ Le Mans Universitรฉ catholique de l'Ouest Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy NCT03865914n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital Transformative Research in Diabetic Nephropathy 2.0 NCT07444203n/a1 site๐Ÿ“ Philadelphia University of Pennsylvania ยท Tests: Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Renin-angiotensin-aldosterone system blockade, Glucagon-like peptidโ€ฆ Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease NCT06846034NA1 site๐Ÿ“ Poitiers Poitiers University Hospital ยท Tests: Hypoxia administration study group, Renal clairance study Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial NCT07396155Phase 1, Phase 21 site๐Ÿ“ Yogyakarta PT. Prodia Stem Cell Indonesia ยท Tests: Umbilical Cord Mesenchymal Stem Cells Transformative Research in Diabetic Nephropathy NCT02986984n/a17 sites๐Ÿ“ Little Rock๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto University of Pennsylvania ยท Tests: There is no intervention Prognostic Imaging Biomarkers for Diabetic Kidney Disease NCT03716401n/a7 sites๐Ÿ“ Turku๐Ÿ“ Bordeaux๐Ÿ“ Bari University of Leeds ยท Tests: MRI (magnetic resonance imaging), US (ultrasound), Renal Biopsy, Positron Emission Tomography (PET), Microvascular Asseโ€ฆ Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease NCT07271186Phase 258 sites๐Ÿ“ Huntsville๐Ÿ“ Little Rock๐Ÿ“ Huntington Beach Regeneron Pharmaceuticals ยท Tests: ALN-ANG3, Evinacumab, Placebo Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845n/a1 site๐Ÿ“ Jinan Zunsong Wang ยท Tests: Imaging Time Paraoxonase and HDL Qualities in Glycaemia and Inflammation NCT02169518n/a1 site๐Ÿ“ Manchester Manchester University NHS Foundation Trust Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy NCT07822152Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: UC-MSCs, Placebo Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes NCT06936670NA2 sites๐Ÿ“ Seattle๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: Inspiratory Muscle Strength Training (IMST), Sham Training Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease NCT06452862n/a1 site๐Ÿ“ Shenyang Shengjing Hospital ยท Tests: Magnetic Resonance Imaging Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community NCT05349955NA13 sites๐Ÿ“ Suzhou๐Ÿ“ Suzhou๐Ÿ“ Suzhou Shanghai Zhongshan Hospital ยท Tests: Intensive guideline algorithm implementation, Conventional guideline algorithm implementation
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy